Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
831 | 3025 | 37.9 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
423 | 3 | CLOSTRIDIUM DIFFICILE//ANTHRAX//CLOSTRIDIUM PERFRINGENS | 28266 |
1686 | 2 | ANTHRAX//BACILLUS ANTHRACIS//BACILLUS CEREUS | 6767 |
831 | 1 | ANTHRAX//BACILLUS ANTHRACIS//PROTECTIVE ANTIGEN | 3025 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTHRAX | authKW | 3467539 | 17% | 66% | 522 |
2 | BACILLUS ANTHRACIS | authKW | 2471287 | 14% | 57% | 430 |
3 | PROTECTIVE ANTIGEN | authKW | 988980 | 5% | 70% | 140 |
4 | LETHAL FACTOR | authKW | 841273 | 3% | 89% | 94 |
5 | ANTHRAX TOXIN | authKW | 564471 | 3% | 73% | 77 |
6 | LETHAL TOXIN | authKW | 504104 | 2% | 78% | 64 |
7 | ANTHRAX VACCINE | authKW | 318503 | 2% | 66% | 48 |
8 | EDEMA FACTOR | authKW | 281803 | 1% | 85% | 33 |
9 | BACTERIAL TOXINS THER EUT SECT | address | 277104 | 1% | 89% | 31 |
10 | CUTANEOUS ANTHRAX | authKW | 273796 | 1% | 94% | 29 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 13969 | 29% | 0% | 876 |
2 | Infectious Diseases | 12058 | 19% | 0% | 582 |
3 | Immunology | 8288 | 26% | 0% | 788 |
4 | Biotechnology & Applied Microbiology | 1137 | 10% | 0% | 289 |
5 | Biochemistry & Molecular Biology | 849 | 18% | 0% | 543 |
6 | Medicine, Research & Experimental | 613 | 6% | 0% | 195 |
7 | Veterinary Sciences | 228 | 4% | 0% | 126 |
8 | Public, Environmental & Occupational Health | 214 | 5% | 0% | 147 |
9 | Biochemical Research Methods | 164 | 3% | 0% | 104 |
10 | Biophysics | 163 | 4% | 0% | 115 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BACTERIAL TOXINS THER EUT SECT | 277104 | 1% | 89% | 31 |
2 | MICROBIAL PATHOGENESIS SECT | 204341 | 1% | 56% | 36 |
3 | SPATIAL EPIDEMIOL ECOL | 149040 | 1% | 62% | 24 |
4 | UNITE TOXINES PATHOGENIE BACTERIENNES | 126805 | 1% | 74% | 17 |
5 | BIOL DEF DIRECTORATE | 108356 | 1% | 38% | 28 |
6 | URA 1858 | 80732 | 0% | 67% | 12 |
7 | MED INFECT DIS | 79984 | 5% | 6% | 139 |
8 | UNITE TOXINES PATHOGENIE BACTERIENNE | 75974 | 1% | 47% | 16 |
9 | GENET MOL TOXINES | 60555 | 0% | 100% | 6 |
10 | IST ZOOPROFILATT SPERIMENTALE PUGLIA BASILICATA | 59359 | 0% | 59% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFECTION AND IMMUNITY | 15453 | 7% | 1% | 203 |
2 | TOXINS | 11851 | 1% | 3% | 41 |
3 | HEALTH SECURITY | 10601 | 0% | 12% | 9 |
4 | EMERGING INFECTIOUS DISEASES | 7818 | 2% | 1% | 67 |
5 | CLINICAL AND VACCINE IMMUNOLOGY | 7697 | 1% | 2% | 45 |
6 | VACCINE | 7358 | 4% | 1% | 116 |
7 | BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE | 7068 | 0% | 5% | 15 |
8 | JOURNAL OF APPLIED MICROBIOLOGY | 5312 | 2% | 1% | 59 |
9 | MOLECULAR ASPECTS OF MEDICINE | 3587 | 0% | 2% | 15 |
10 | CELLULAR MICROBIOLOGY | 3586 | 1% | 1% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTHRAX | 3467539 | 17% | 66% | 522 | Search ANTHRAX | Search ANTHRAX |
2 | BACILLUS ANTHRACIS | 2471287 | 14% | 57% | 430 | Search BACILLUS+ANTHRACIS | Search BACILLUS+ANTHRACIS |
3 | PROTECTIVE ANTIGEN | 988980 | 5% | 70% | 140 | Search PROTECTIVE+ANTIGEN | Search PROTECTIVE+ANTIGEN |
4 | LETHAL FACTOR | 841273 | 3% | 89% | 94 | Search LETHAL+FACTOR | Search LETHAL+FACTOR |
5 | ANTHRAX TOXIN | 564471 | 3% | 73% | 77 | Search ANTHRAX+TOXIN | Search ANTHRAX+TOXIN |
6 | LETHAL TOXIN | 504104 | 2% | 78% | 64 | Search LETHAL+TOXIN | Search LETHAL+TOXIN |
7 | ANTHRAX VACCINE | 318503 | 2% | 66% | 48 | Search ANTHRAX+VACCINE | Search ANTHRAX+VACCINE |
8 | EDEMA FACTOR | 281803 | 1% | 85% | 33 | Search EDEMA+FACTOR | Search EDEMA+FACTOR |
9 | CUTANEOUS ANTHRAX | 273796 | 1% | 94% | 29 | Search CUTANEOUS+ANTHRAX | Search CUTANEOUS+ANTHRAX |
10 | EDEMA TOXIN | 232529 | 1% | 96% | 24 | Search EDEMA+TOXIN | Search EDEMA+TOXIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOAYERI, M , LEPPLA, SH , VRENTAS, C , POMERANTSEV, AP , LIU, SH , (2015) ANTHRAX PATHOGENESIS.ANNUAL REVIEW OF MICROBIOLOGY, VOL 69. VOL. 69. ISSUE . P. 185 -208 | 220 | 91% | 12 |
2 | BOUZIANAS, DG , (2010) CURRENT AND FUTURE MEDICAL APPROACHES TO COMBAT THE ANTHRAX THREAT.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 53. ISSUE 11. P. 4305 -4331 | 177 | 80% | 25 |
3 | BREY, RN , (2005) MOLECULAR BASIS FOR IMPROVED ANTHRAX VACCINES.ADVANCED DRUG DELIVERY REVIEWS. VOL. 57. ISSUE 9. P. 1266-1292 | 166 | 93% | 66 |
4 | KAUR, M , SINGH, S , BHATNAGAR, R , (2013) ANTHRAX VACCINES: PRESENT STATUS AND FUTURE PROSPECTS.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 8. P. 955 -970 | 141 | 86% | 13 |
5 | CYBULSKI, RJ , SANZ, P , O'BRIEN, AD , (2009) ANTHRAX VACCINATION STRATEGIES.MOLECULAR ASPECTS OF MEDICINE. VOL. 30. ISSUE 6. P. 490-502 | 141 | 92% | 29 |
6 | NESTOROVICH, EM , BEZRUKOV, SM , (2014) DESIGNING INHIBITORS OF ANTHRAX TOXIN.EXPERT OPINION ON DRUG DISCOVERY. VOL. 9. ISSUE 3. P. 299 -318 | 126 | 84% | 9 |
7 | OHANJANIAN, L , REMY, KE , LI, Y , CUI, X , EICHACKER, PQ , (2015) AN OVERVIEW OF INVESTIGATIONAL TOXIN-DIRECTED THERAPIES FOR THE ADJUNCTIVE MANAGEMENT OF BACILLUS ANTHRACIS INFECTION AND SEPSIS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 24. ISSUE 7. P. 851 -865 | 122 | 89% | 1 |
8 | LOWE, DE , GLOMSKI, IJ , (2012) CELLULAR AND PHYSIOLOGICAL EFFECTS OF ANTHRAX EXOTOXIN AND ITS RELEVANCE TO DISEASE.FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. VOL. 2. ISSUE . P. - | 118 | 91% | 13 |
9 | TOURNIER, JN , ULRICH, RG , QUESNEL-HELLMANN, A , MOHAMADZADEH, M , STILES, BG , (2009) ANTHRAX, TOXINS AND VACCINES: A 125-YEAR JOURNEY TARGETING BACILLUS ANTHRACIS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 7. ISSUE 2. P. 219 -236 | 133 | 84% | 26 |
10 | MOAYERI, M , LEPPLA, SH , (2009) CELLULAR AND SYSTEMIC EFFECTS OF ANTHRAX LETHAL TOXIN AND EDEMA TOXIN.MOLECULAR ASPECTS OF MEDICINE. VOL. 30. ISSUE 6. P. 439 -455 | 103 | 88% | 114 |
Classes with closest relation at Level 1 |